Spineway (FRA:37S) Total Equity: €23.06 Mil (As of Dec. 2025)


FRA:37S Spineway FRA:37S
45 GF Score
Price €0.12
GF Value €166.93
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Spineway Total Equity?

Spineway FRA:37S 45 Total Equity is €23.06 Mil as of Dec. 2025. GuruFocus rates FRA:37S with a GF Score™ of 45/100 and a GF Value™ of €166.93 (Possible Value Trap). The stock has 4 warning signs investors should review.

Spineway's total equity for the quarter that ended in Dec. 2025 was €23.06 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Spineway Total Equity Historical Data

* Premium members only.

The historical data trend for Spineway's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spineway Total Equity Chart

Spineway Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.88 22.01 19.05 24.24 23.06

Spineway Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.05 21.25 24.24 23.86 23.06
FRA:37S
45GF Score
Spineway FRA:37S
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spineway Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Spineway's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=29.464-6.404
=23.06

Spineway's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=29.464-6.404
=23.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €23.06 Mil mean?
Spineway (FRA:37S) has a Total Equity of €23.06 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Spineway and its competitors.
Is Spineway's Total Equity too high?
Spineway's current Total Equity is €23.06 Mil. Overall, Spineway has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Spineway's Total Equity compare to ISRG and BDX?
Spineway's Total Equity of €23.06 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Spineway and its competitors. Spineway's current Total Equity is €23.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineway stock overvalued right now?
Based on GuruFocus' analysis, Spineway (FRA:37S) is currently considered Possible Value Trap. The stock's GF Value™ is €166.93, compared to a current price of €0.12 — trading 99.9% below its estimated fair value. The current Total Equity is €23.06 Mil. Spineway's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Spineway (FRA:37S), the current Total Equity is €23.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spineway (FRA:37S) Overvalued in 2026?

Based on GuruFocus' analysis, Spineway stock appears to be undervalued. The current stock price of €0.12 is trading 99.9% below its estimated GF Value™ of €166.93. GuruFocus considers Spineway to be Possible Value Trap.

Key valuation signals for FRA:37S:

  • Total Equity: €23.06 Mil
  • GF Value™: €166.93 vs. price of €0.12 (99.9% below fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the FRA:37S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spineway Business Description

Other Exchanges ALSPW:France
Address 7 Allee Moulin Berger, Ecully, FRA, 69130
Spineway designs produce and markets implant lines and ancillary surgical equipment used for the treatment of severe disorders of the spinal column. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, and other such medical instruments.
45GF Score

Get the complete analysis for FRA:37S

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price
€166.93
GF Value